Navigation Links
antibacterials in Medical News

Antibacterial chemical disrupts hormone activities

...understand, said one author, Bill Lasley, a UC Davis expert on reproductive toxicology and professor emeritus of veterinary medicine. More analyses of antibacterials and endocrine effects are planned, he said. Consumers should not take this study as guidance on whether to use triclocarban-containing products, La...

Infectious diseases experts applaud bill against 'bad bugs'

...son and Ferguson are taking to tackle the problem of antimicrobial resistance. Infectious diseases physicians have watched in dismay for years as the antibacterials and other antimicrobials we rely upon to treat our patients have lost their power. To make matters worse, there are very few new drugs in the pipel...

New Ribosome Finding Could Lead to Antiviral Therapies

...ding how these mutants affect the interactions between ribosomes and factors that lead to drug resistance can provide the foundation for design of new antibacterials to counter resistance of pathogens to drugs,” said Dinman. “This study also provides a basis for deeper insight into design of small molecule antivira...
antibacterials in Medical Technology

Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki

... products are targeting the global hospital antibiotic market, which was worth an estimated US$17bn in 2008.[1] Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009

...ebsite at www.rib-x.com . (1) 100 Great Investigational Drugs; R&D Directions; March 2009 (2) Commercial and Pipeline Insight: Hospital antibacterials - A market beyond MRSA; Datamonitor; August 24, 2007 For further information please contact: Media: Irma Gomez-Dib FD Life Scie...

Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)

...et, which was worth an estimated $15bn in 2007 according to information derived from the IMS Midas(R) database. Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Novexel's NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections

... market, which was worth an estimated $15bn in 2007 according to information derived from the IMS Midas(R) database. Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting

... market, which was worth an estimated $15bn in 2007 according to information derived from the IMS Midas(R) database. Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia

... market, which was worth an estimated $15bn in 2007 according to information derived from the IMS Midas(R) database. Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA

... 1:15 pm) -- F1-334: Discovery and SAR of a Novel Series of Pyrimidine antibacterials Targeting Methionyl-tRNA Synthase (MetRS) -- F1-335: In Vitro Activi...11:15 am - 12:15 pm) -- F2-2070: Structure Guided Design of Pyrimidine antibacterials Targeting Methionyl-tRNA Synthase (MetRS) Copies of these posters wil...

Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences

...re-Based Discovery to Define Novel Antibiotics Targeting the 50S Ribosomal Subunit." RX-04 is Rib-X's de novo design of three completely new series of antibacterials showing promising activity against serious multidrug resistant Gram-negative pathogens, including, Pseudomonas aeruginosa, Stenotrophomonas maltophili...
antibacterials in Biological News

New antibacterials being developed to tackle MRSA superbug

A novel antibacterial medicine that kills the superbug MRSA is being developed under a new scheme launched by the Wellcome Trust. The Seeding Drug Discovery initiative is aimed at catalysing the development of new drugs in areas of unmet need. Prolysis, an R&D company based in Oxford, has re...

Pharmaceutical use in Norwegian fish farming in 2001-2007

...r sea lice and fungi. The figures are based on sales from wholesalers to pharmacies and from feed mills to breeders. After an increase in sales of antibacterials from 2002-2006, sales in 2007 returned to levels seen in 2001. Prescription-based statistics from the Norwegian Food Safety Authority for the period 2...
antibacterials in Biological Technology

Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush

...'s products are targeting the global hospital antibiotic market, which was worth an estimated $17bn in 2008.[1] Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing

...ion on the Rib-X mission and the pipeline, please visit the Company website at www.rib-x.com . (1) Commercial and Pipeline Insight: Hospital antibacterials - A market beyond MRSA; Datamonitor; August 24, 2007 ...

GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C

...r in an entrepreneurial environment and size of small biotechnology companies. The ID CEDD currently consists of three discovery units for antivirals, antibacterials and medicines against diseases of the developing world. It focuses on building an innovative pipeline through both internal efforts and external allia...

GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program

...he U.S. Department of Defense (DOD), to identify and develop a new class of antibacterials targeting both Gram negative biothreats and conventional Gram negative hosp...e Threat Reduction Agency. "This research is needed to identify and deliver antibacterials from entirely new classes to defend against potential biothreat outbreaks a...
antibacterials in Biological Definition

Antibiotic

...ic corticosteroid . Antibiotic misuse Common forms of antibiotic misuse include taking an inappropriate antibiotic, in particular the use of antibacterials for viral infections like the common cold, and failure to take the entire prescribed course of the antibiotic, usually because the patient feels bette...
Other Tags
(Date:5/25/2015)... A recent report for Mass Live ... died as a direct result of an opiate overdose in ... rise in overdose deaths attributed to prescription opiate medications, and ... care about geography. This issue doesn’t care about race. This ... class.” As the state of Mass. reels from the effects ...
(Date:5/25/2015)... 2015 ProDrop Light Show allows users ... light backdrops with a click of a mouse. Users have full ... all within Final Cut Pro X. , ProDrop Light Show gives ... zones, kaleidoscope and much more leaving infinite possibilities all within Final ... zones and text presets, users can apply their very own media ...
(Date:5/25/2015)... 2015 Tunstall Americas announces major investment ... level of service to its Medical Answering Service customers. ... restructuring of resources, Tunstall now provides a seamless transition ... Answering Service to ensure superior patient satisfaction. ... invested over $10 million in expanded facilities and the ...
(Date:5/24/2015)... Pacific Prime has announced that they have launched the ... cost of individual international health insurance. Titled: The Cost of Health ... of health insurance in six top expat destinations, which are also ... Hong Kong , Singapore , China , ... the UK , Article 2 presents an in-depth look ...
(Date:5/24/2015)... 24, 2015 For people who are ... Enterokinase Industry, 2009-2019 Market Research Report would be an ... exhaustive study on the present market scenario of this ... the growing Chinese market of this industry. The report ... status of the manufacturers in this industry. The report ...
Breaking Medicine News(10 mins):Health News:Opioid Deaths Increase by 33 Percent Since 2012 in Mass. 2Health News:Developers at Pixel Film Studios Release of ProDrop Light Show for Final Cut Pro X. 2Health News:Tunstall Introduces New Medical Answering Service for the 21st Century Practice 2Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4
(Date:4/20/2015)... 2015 The announcement comes as ... Records Management (GRM), Ireland,s foremost records ... Having built up an impressive track record of clients within ... within the records management sector in Dubai ... GCC staffbase and employ a further eight staff members at ...
(Date:4/14/2015)...  HYPR Corp. today announced it has joined ... tm , an industry consortium transforming online authentication ... technology and collaborate to deliver open specifications for ... and private, and easier to use. ... sensitive user information and eliminates the dependency on ...
(Date:4/13/2015)... , April 13, 2015 ... Research, "Global Biometrics Market Forecast & Opportunities, 2020", the ... CAGR of around 14% till 2020. The biometrics ... large scale implementation and review of biometric management ... of new products with greater efficiency, are resulting ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
Other Contents